Advancing Medicine. Precisely.
Customized phage therapies to eradicate
harmful bacteria in chronic diseases
BiomX is developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic dermatitis, and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.Learn More
Our technological platform for the discovery and development of phage therapies originates from the labs of world-leading scientists from the Weizmann Institute of Science and MIT.Meet Our Team
News and EventsView All
Join Our Team
At BiomX, we value each and every individual. By working with us, our employees harness their talent and cultivate our company with innovation, purpose, and growth. Come be a part of our cutting-edge team of innovators, scientists, and game-changers on a mission to develop the most advanced phage therapeutics.